(Q38351931)

English

The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Alexander Spiel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

7

object named as

Bernd Jilma

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Florian B Mayr

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Nathalie Ladani

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Patricia G Wagner

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Robert G Schaub

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

James C Gilbert

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 August 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

334-340

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

von Willebrand factor, endothelial dysfunction, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Platelet function predicts myocardial damage in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals.

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

The effect of ex vivo anticoagulants on whole blood platelet aggregation

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Simultaneous Modeling of Abciximab Plasma Concentrations and ex Vivo Pharmacodynamics in Patients Undergoing Coronary Angioplasty

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Heparin therapy leads to platelet activation and prolongation of PFA-100 closure time

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1080%2F09537100903085927

21 January 2018

Identifiers

10.1080/09537100903085927

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637097%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38351931&oldid=1533012143"